(SeaPRwire) –   LOUISVILLE, Colo., March 20, 2026 – (TSX: CWEB) (OTCQB: CWBHF) Charlotte’s Web Holdings, Inc. (the “Company” or “Charlotte’s Web“), a leader in botanical wellness and hemp extract innovation, expresses its gratitude to the Centers for Medicare & Medicaid Services (CMS) and the Administration for their efforts in facilitating access to qualified full-spectrum hemp products. This progress is highlighted in the CMS Innovation Center’s new Substance Access Beneficiary Engagement Incentive (BEI) guidance. Under this framework, CMS identifies eligible hemp products as those administered orally with a THC content of up to 3 mg per serving, a limit that includes non-intoxicating full-spectrum CBD products. This initiative encourages clinical discussions between patients and providers regarding hemp options, supporting science-based policies that emphasize consumer safety and product excellence.

“We are thankful for the thoughtful strategy CMS has taken to increase access and foster professional, evidence-based conversations about hemp wellness in clinical settings,” stated Bill Morachnick, CEO of Charlotte’s Web. “This initiative is in harmony with our goal to provide safe, high-quality, and scientifically-supported hemp products. We remain dedicated to advocating for practical legislation that protects consumers and maintains the integrity of our industry.”

Charlotte’s Web will continue to support policy advancements that prioritize safety, transparency, and the availability of high-quality full-spectrum hemp products.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation based in Louisville, Colorado, is a premier botanical wellness company specializing in hemp extract products. The Company offers a wide range of products, including CBD oil tinctures, CBD gummies for sleep and recovery, CBN and CBG gummies, hemp-derived THC microdose gummies, functional mushroom supplements, CBD capsules, topicals, and CBD products for pets. Through its vertically integrated operations, Charlotte’s Web ensures strict quality control and consistency via comprehensive analytical testing. Its products are available through various retailers, healthcare professionals, and the Company’s website at www.charlottesweb.com.

Forward-Looking Information

This press release contains forward-looking statements as defined by securities laws. These statements are typically identified by terms such as “anticipate,” “believe,” “expect,” “plan,” “will,” and similar words. Such statements are not guarantees of future performance, and readers are advised not to place undue reliance on them. This release includes projections regarding product eligibility under CMS programs, the potential impact of federal healthcare policies on hemp products, and the Company’s market position. These statements are based on various assumptions and involve risks, including economic conditions, regulatory changes, and the possibility that products may not meet eligibility standards. Further details on these risks can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other filings with the SEC and Canadian regulators. The Company does not undertake to update these statements except as required by law. All forward-looking information is subject to these cautionary notes.

SOURCE Charlotte’s Web Holdings, Inc.